デフォルト表紙
市場調査レポート
商品コード
1601138

眼科用ビスコーサージカルデバイス市場:製品、用途、エンドユーザー別-2025~2030年の世界予測

Ophthalmic Viscosurgical Devices Market by Product (Cohesive, Combined, Dispersive), Application (Cataract Surgery, Glaucoma Surgery, Keratoplasty), End User - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 186 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
眼科用ビスコーサージカルデバイス市場:製品、用途、エンドユーザー別-2025~2030年の世界予測
出版日: 2024年10月31日
発行: 360iResearch
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

眼科用ビスコーサージカルデバイス市場は、2023年に6億4,833万米ドルと評価され、2024年には7億286万米ドルに達すると予測され、CAGR 8.81%で成長し、2030年には11億7,129万米ドルになると予測されています。

眼科用ビスコーサージカルデバイス(OVD)は眼科において重要な役割を担っており、主に白内障やその他の眼内手術の際に使用され、前房深度の維持、角膜内皮細胞の保護、硝子体面の安定化を図る。世界の高齢化により白内障やそれに関連する眼科疾患の有病率が高まる中、OVDの必要性は高まっています。これらのデバイスは、外科手術を容易にし、術後の合併症を最小限に抑えながら、正確さと安全性を確保することに応用されています。最終用途には、病院、眼科クリニック、外来手術センターなどが含まれ、先進的手術手技や機器を選択する傾向が強まっています。市場開拓は、低侵襲手術に対する需要の高まり、眼科製品の技術進歩、新興国市場における検眼医や眼科医の増加といった要因に影響されています。さらに、政府の支援と医療保険により、眼科医療サービスへの幅広いアクセスと手頃な価格が可能になり、市場の展望を後押ししています。アジア太平洋とラテンアメリカの未開拓市場には新たなビジネス機会が眠っており、そこでは眼科医療への投資と啓蒙キャンペーンが増加しています。企業は販売網を拡大し、現地の医療機関と提携することで、大きな市場シェアを獲得できる可能性があります。しかし、同市場は、外科手術や器具のコストが高いこと、規制当局の承認が厳しいこと、OVDの不適切な使用から生じる合併症の可能性があることなどの制約に直面しています。技術革新は、費用対効果が高く、生分解性で生体適合性のあるOVDの開発に焦点を当て、患者の転帰と機器の有効性を高めることができます。さらに、個別化医療とデジタルヘルス技術の統合に関する調査によって、新たな成長の道が開ける可能性もあります。同市場は熾烈な競争を特徴としており、主要企業は足場を維持するために戦略的M&A、製品イノベーション、地域拡大に注力しています。このため、企業は戦略的パートナーシップ、研究開発投資、技術的進歩を重視しなければならないです。

主要市場の統計
基準年[2023年] 6億4,833万米ドル
予測年[2024年] 7億286万米ドル
予測年[2030年] 11億7,129万米ドル
CAGR(%) 8.81%

市場力学:急速に進化する眼科用ビスコーサージカルデバイス市場の主要市場洞察を公開

眼科用ビスコーサージカルデバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 眼科と眼疾患患者の増加
    • 設備の整った医療インフラの利用可能性と医薬品認可数の増加
  • 市場抑制要因
    • 低侵襲性と非侵襲性の治療オプションの利用可能性
  • 市場機会
    • 新しいタイプの眼科用ビスコーサージカルデバイスの採用
    • 眼科手術用粘着剤の継続的な臨床的検討
  • 市場課題
    • 眼科手術のための熟練した専門家の限られた入手可能性

ポーターのファイブフォース:眼科用ビスコーサージカルデバイス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:眼科用ビスコーサージカルデバイス市場における外部からの影響の把握

外部マクロ環境要因は、眼科用ビスコーサージカルデバイス市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析:眼科用ビスコーサージカルデバイス市場における競合情勢の把握

眼科用ビスコーサージカルデバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス:眼科用ビスコーサージカルデバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、眼科用ビスコーサージカルデバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目セグメントを網羅した包括的な市場分析を提供しています。

1.市場の浸透度:産業主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度:新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化:最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、地域はどこか?

3.市場を形成する主要技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 眼科疾患の増加
      • 設備の整った医療インフラの整備と医薬品承認数の増加
    • 抑制要因
      • 低侵襲と非侵襲治療オプションの利用可能性
    • 機会
      • 新しいタイプの眼科用ビスコーサージカルデバイスの採用
      • 眼科粘膜手術用接着剤の臨床的検討の継続
    • 課題
      • 眼科手術の熟練した専門家の不足
  • 市場セグメンテーション分析
    • 製品:多用途性と手術の安全性により、凝集性と分散性OVDの人気が高まっている
    • 用途:患者の安全を確保しながら鮮明な視覚を提供する白内障手術と角膜移植手術におけるOVDの使用が増加
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 法律
    • 環境
  • 顧客のカスタマイズ

第6章 眼科用ビスコーサージカルデバイス市場:製品別

  • イントロダクション
  • 凝集
  • 組み合わせ
  • 分散

第7章 眼科用ビスコーサージカルデバイス市場:用途別

  • イントロダクション
  • 白内障手術
  • 緑内障手術
  • 角膜移植

第8章 眼科用ビスコーサージカルデバイス市場:エンドユーザー別

  • イントロダクション
  • 外来手術センター
  • 眼科専門クリニック
  • 病院

第9章 南北アメリカの眼科用ビスコーサージカルデバイス市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋の眼科用ビスコーサージカルデバイス市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの眼科用ビスコーサージカルデバイス市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
    • Coherusが眼科事業をSandozに売却
    • RaynerがSophiの買収を発表
    • Bausch + Lombが米国で新製品眼科用ビスコーサージカルデバイスを発売

企業一覧

  • Bausch & Lomb Incorporated
  • Amring Pharmaceuticals Inc.
  • Advin Health Care
  • SERVImed Industrial S.p.A.
  • Rayner Group
  • Johnson & Johnson Services, Inc.
  • Lifecore Biomedical, Inc.
  • Bohus BioTech AB
  • Ophtechnics Unlimited
  • Fidia Farmaceutici S.p.A.
  • Alcon Inc.
  • Precision Lens
  • Truviz Ophthalmic
  • Ildong Hyaltech Co., Ltd.
  • Bloomage BIoTechnology Corporation Limited
  • Henan Universe Intraocular Lens Research and Manufacture Co., Ltd.
  • ALBOMED GmbH
  • LG Chem Life Sciences
  • Beaver-Visitec International, Inc.
  • Kewpie Corporation
  • CIMA Technology, Inc.
  • Carl Zeiss AG
  • Advanced BioMatrix
  • Maxigen BIoTech Inc.
  • Contipro a.s.
図表

LIST OF FIGURES

  • FIGURE 1. OPHTHALMIC VISCOSURGICAL DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. OPHTHALMIC VISCOSURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. OPHTHALMIC VISCOSURGICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPHTHALMIC VISCOSURGICAL DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OPHTHALMIC VISCOSURGICAL DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COHESIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COMBINED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY DISPERSIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY CATARACT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY GLAUCOMA SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY KERATOPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY EYE SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM OPHTHALMIC VISCOSURGICAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. OPHTHALMIC VISCOSURGICAL DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. OPHTHALMIC VISCOSURGICAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-036C5CF3B495

The Ophthalmic Viscosurgical Devices Market was valued at USD 648.33 million in 2023, expected to reach USD 702.86 million in 2024, and is projected to grow at a CAGR of 8.81%, to USD 1,171.29 million by 2030.

Ophthalmic Viscosurgical Devices (OVDs) play a crucial role in ophthalmology, primarily used during cataract and other intraocular surgeries to maintain anterior chamber depth, protect corneal endothelial cells, and stabilize the vitreous face. With the increasing prevalence of cataract and related ophthalmic conditions due to an aging global population, the necessity for OVDs is growing. These devices find application in facilitating surgical procedures and ensuring precision and safety while minimizing post-operative complications. The end-use scope encompasses hospitals, ophthalmic clinics, and ambulatory surgical centers, which are increasingly opting for advanced surgical techniques and devices. Market growth is influenced by factors such as the rising demand for minimally invasive surgeries, technological advancements in ophthalmic products, and an increasing number of optometrists and ophthalmologists in developing regions. Furthermore, government support and healthcare insurance have enabled wider accessibility and affordability of eye care services, boosting market prospects. Emerging opportunities lie in the untapped markets of the Asia-Pacific and Latin America regions, where increasing healthcare investments and awareness campaigns about ocular health are underway. Companies could benefit by expanding their distribution networks and partnering with local health organizations to capture a significant market share. However, the market faces limitations such as the high cost of surgical procedures and devices, stringent regulatory approvals, and potential complications arising from improper use of OVDs. Innovation could focus on developing cost-effective, biodegradable, and bio-compatible OVDs, enhancing patient outcomes and device efficacy. Moreover, research on personalized medicine and the integration of digital health technologies could unlock new avenues for growth. The market is characterized by intense competition, with key players focusing on strategic mergers and acquisitions, product innovations, and regional expansions to maintain their foothold. Thus, businesses must emphasize strategic partnerships, R&D investment, and technological advancements to thrive in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 648.33 million
Estimated Year [2024] USD 702.86 million
Forecast Year [2030] USD 1,171.29 million
CAGR (%) 8.81%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmic Viscosurgical Devices Market

The Ophthalmic Viscosurgical Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Cases of the Ophthalmic and Ocular Disorders
    • Availability of Well-Equipped Healthcare Infrastructure and Increasing Number of Drugs Approvals
  • Market Restraints
    • Availability of Minimally Invasive and Non-Invasive Treatment Options
  • Market Opportunities
    • Introduction of New Types of Ophthalmic Viscosurgical Devices
    • Ongoing Clinical Consideration of Adhesive for Ophthalmic Viscosurgeries
  • Market Challenges
    • Limited Availability of Skilled Professionals for Ophthalmic Procedures

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmic Viscosurgical Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmic Viscosurgical Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmic Viscosurgical Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmic Viscosurgical Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmic Viscosurgical Devices Market

A detailed market share analysis in the Ophthalmic Viscosurgical Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmic Viscosurgical Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmic Viscosurgical Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmic Viscosurgical Devices Market, highlighting leading vendors and their innovative profiles. These include Bausch & Lomb Incorporated, Amring Pharmaceuticals Inc., Advin Health Care, SERVImed Industrial S.p.A., Rayner Group, Johnson & Johnson Services, Inc., Lifecore Biomedical, Inc., Bohus BioTech AB, Ophtechnics Unlimited, Fidia Farmaceutici S.p.A., Alcon Inc., Precision Lens, Truviz Ophthalmic, Ildong Hyaltech Co., Ltd., Bloomage Biotechnology Corporation Limited, Henan Universe Intraocular Lens Research and Manufacture Co., Ltd., ALBOMED GmbH, LG Chem Life Sciences, Beaver-Visitec International, Inc., Kewpie Corporation, CIMA Technology, Inc., Carl Zeiss AG, Advanced BioMatrix, Maxigen Biotech Inc., and Contipro a.s..

Market Segmentation & Coverage

This research report categorizes the Ophthalmic Viscosurgical Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cohesive, Combined, and Dispersive.
  • Based on Application, market is studied across Cataract Surgery, Glaucoma Surgery, and Keratoplasty.
  • Based on End User, market is studied across Ambulatory Surgical Center, Eye Specialty Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Cases of the Ophthalmic and Ocular Disorders
      • 5.1.1.2. Availability of Well-Equipped Healthcare Infrastructure and Increasing Number of Drugs Approvals
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of Minimally Invasive and Non-Invasive Treatment Options
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of New Types of Ophthalmic Viscosurgical Devices
      • 5.1.3.2. Ongoing Clinical Consideration of Adhesive for Ophthalmic Viscosurgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Limited Availability of Skilled Professionals for Ophthalmic Procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Growing popularity of cohesive and dispersive OVDs due to their versatility and surgical safety
    • 5.2.2. Application: Increasing uses of OVDs in cataract and keratoplasty surgeries offering clear visualizations while ensuring patient's safety
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Ophthalmic Viscosurgical Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cohesive
  • 6.3. Combined
  • 6.4. Dispersive

7. Ophthalmic Viscosurgical Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cataract Surgery
  • 7.3. Glaucoma Surgery
  • 7.4. Keratoplasty

8. Ophthalmic Viscosurgical Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Center
  • 8.3. Eye Specialty Clinics
  • 8.4. Hospitals

9. Americas Ophthalmic Viscosurgical Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Ophthalmic Viscosurgical Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmic Viscosurgical Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Coherus is Selling Off Its Ophthalmology Franchise to Sandoz
    • 12.3.2. Rayner Announces Acquisition of Sophi
    • 12.3.3. Bausch + Lomb Launches New Ophthalmic Viscosurgical Devices in the United States

Companies Mentioned

  • 1. Bausch & Lomb Incorporated
  • 2. Amring Pharmaceuticals Inc.
  • 3. Advin Health Care
  • 4. SERVImed Industrial S.p.A.
  • 5. Rayner Group
  • 6. Johnson & Johnson Services, Inc.
  • 7. Lifecore Biomedical, Inc.
  • 8. Bohus BioTech AB
  • 9. Ophtechnics Unlimited
  • 10. Fidia Farmaceutici S.p.A.
  • 11. Alcon Inc.
  • 12. Precision Lens
  • 13. Truviz Ophthalmic
  • 14. Ildong Hyaltech Co., Ltd.
  • 15. Bloomage Biotechnology Corporation Limited
  • 16. Henan Universe Intraocular Lens Research and Manufacture Co., Ltd.
  • 17. ALBOMED GmbH
  • 18. LG Chem Life Sciences
  • 19. Beaver-Visitec International, Inc.
  • 20. Kewpie Corporation
  • 21. CIMA Technology, Inc.
  • 22. Carl Zeiss AG
  • 23. Advanced BioMatrix
  • 24. Maxigen Biotech Inc.
  • 25. Contipro a.s.